Stanford Neurosurgery

10/24/2025

Chief resident, Danny Huang was awarded the Stereotactic and Functional Neurosurgery Resident Basic Science Award for his abstract "Invasive Network Mapping Enables
Personalized Multi-nodal Deep Brain Stimulation For Treatment-refractory Chronic Pain.” Congratulations on this fantastic achievement!

10/21/2025

Earlier this month, our team welcomed visiting professor Dr. Dean Chou who presented his talk: “Adult scoliosis and modern treatment principles: does everyone need T10 to the pelvis?” Dr. Chou is the Bennett M. Stein Professor of Neurosurgery and the Chief of the Spine Division and Vice Chair of Neurosurgery at the Columbia University.

10/20/2025

New research from the Prolo Lab reveals that circadian rhythms play a key role in pediatric high-grade glioma treatment. The timing of chemotherapy delivery may significantly impact treatment efficacy and the study shows that temozolomide sensitivity varies with circadian gene expression cycles—opening doors for chronotherapy approaches in pediatric brain cancer.

Learn more:
https://doi.org/10.1038/s41598-025-17461-9

Pediatric high-grade gliomas (pHGG) are highly invasive with poor survival outcomes. Timing of Temozolomide administration has been shown to affect survival of adult patients with glioblastoma. We investigated whether pHGGs express circadian genes rhythmically and whether underlying rhythms affect T...

10/17/2025

🌟Breast Cancer Awareness Month Feature: Meet Shruti Jain, MS, PhD, Basic Life Research Scientist in the Melanie Hayden-Gephart Lab and a brain cancer researcher who is also a triple negative breast cancer survivor. She is dedicated to raising awareness for early detection. 💖 With a groundbreaking model to study how cancer evades the brain's immune system, Shruti is inspired by her mentor, Dr. Hayden to empower others and make a difference. ✨

10/17/2025

This October, we're raising awareness for arteriovenous malformations (AVMs)—abnormal tangles of blood vessels that can occur in the brain and spine. Early detection and treatment are crucial. Our neurosurgery team is dedicated to advancing care and improving outcomes for AVM patients.